CSIMarket
 


Atara Biotherapeutics, Inc.  (ATRA)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare

Atara Biotherapeutics's Working Capital Ratio

ATRA's quarterly Working Capital Ratio and Current Assets, Current Liabilities growth




ATRA Working Capital Ratio (Mar 31 2019)
I. Quarter
(Dec 31 2018)
IV. Quarter
(Sep 30 2018)
III. Quarter
(Jun 30 2018)
II. Quarter
(Mar 31 2018)
I. Quarter
Y / Y Current Liabilities Change 71.11 % -12.14 % 40.45 % 79.19 % 88.51 %
Y / Y Current Assets Change -39.36 % 86.71 % 80.87 % 91.05 % 75.77 %
Working Capital Ratio MRQ 9.96 15.48 16.08 20.66 28.11
Overall Ranking # # # # #
Seq. Current Liabilities Change 21.21 % -10.47 % 12.75 % 39.83 % -37.76 %
Seq. Current Assets Change -21.98 % -13.8 % -12.26 % 2.77 % 140.21 %



Working Capital Ratio first quarter 2019 Comment
Due to increase in Current Liabilities in the first quarter 2019, Working Capital Ratio fell to 9.96 below Atara Biotherapeutics, Inc. average.

Within Biotechnology & Drugs industry 45 other companies have achieved higher Working Capital Ratio than Atara Biotherapeutics in first quarter 2019. While total ranking remained unchanged compare to previous quarter at no. .

Explain Working Capital Ratio
Where is ATRA most successful ?
Working Capital Ratio ATRA on the trailing twelve month basis
Working Capital Ratio first quarter 2019 Company Ranking
Within: No.
Biotechnology & Drugs Industry # 46
Healthcare Sector # 137
Overall Market # 392


Working Capital Ratio Statistics
High Average Low
52.75 25.56 7.28
(Sep 30 2015)   (Dec 31 2017)




Financial Statements
Atara Biotherapeutics's Current Liabilities $ 25 Millions Visit ATRA's Balance sheet
Atara Biotherapeutics's Current Assets $ 251 Millions Visit ATRA's Balance sheet
Source of ATRA's Sales Visit ATRA's Sales by Geography




Companies with similar Working Capital Ratio in the quarter endingMar 31 2019, within Biotechnology & Drugs Industry Working Capital RatioMar 31 2019 MRQ Current AssetsMar 31 2019 MRQ Current Liabilities
Voyager Therapeutics, Inc.  25.70 $ 365.167  Millions$ 14.210  Millions
Catalyst Biosciences, Inc.  24.94 $ 109.002  Millions$ 4.370  Millions
Urogen Pharma Ltd.  24.16 $ 248.295  Millions$ 10.277  Millions
Casi Pharmaceuticals, Inc.  21.52 $ 107.685  Millions$ 5.004  Millions
Enzon Pharmaceuticals, Inc.  19.80 $ 11.584  Millions$ 0.585  Millions
Pulse Biosciences, Inc.  19.62 $ 53.351  Millions$ 2.719  Millions
Acceleron Pharma Inc  19.26 $ 448.273  Millions$ 23.270  Millions
Eidos Therapeutics, Inc.  19.04 $ 149.296  Millions$ 7.841  Millions
Lixte Biotechnology Holdings, Inc.  18.77 $ 3.955  Millions$ 0.211  Millions
Vical Inc  18.39 $ 46.357  Millions$ 2.521  Millions
Adverum Biotechnologies, Inc.  18.20 $ 193.137  Millions$ 10.610  Millions
Myokardia Inc  18.00 $ 563.106  Millions$ 31.291  Millions
Audentes Therapeutics, Inc.  15.99 $ 373.155  Millions$ 23.331  Millions
Crispr Therapeutics Ag  15.85 $ 450.127  Millions$ 28.398  Millions
Cannabics Pharmaceuticals Inc.  15.80 $ 5.942  Millions$ 0.376  Millions
Cohbar, Inc.  15.55 $ 19.743  Millions$ 1.270  Millions
Strongbridge Biopharma Plc  15.37 $ 115.150  Millions$ 7.494  Millions
Cytrx Corp  15.13 $ 21.458  Millions$ 1.418  Millions
Regenxbio Inc.  14.21 $ 303.884  Millions$ 21.390  Millions
Aerpio Pharmaceuticals, Inc.  13.84 $ 54.299  Millions$ 3.924  Millions
Unity Biotechnology, Inc.  13.67 $ 151.840  Millions$ 11.111  Millions
Tracon Pharmaceuticals, Inc.  13.13 $ 33.088  Millions$ 2.520  Millions
Arcus Biosciences, Inc.  12.89 $ 245.015  Millions$ 19.003  Millions
Oncocyte Corp  12.82 $ 40.993  Millions$ 3.197  Millions
Proteostasis Therapeutics, Inc.  12.73 $ 108.465  Millions$ 8.523  Millions
Oxford Immunotec Global Plc  12.60 $ 218.215  Millions$ 17.319  Millions
Neogen Corp  12.33 $ 422.602  Millions$ 34.268  Millions
Curis Inc  12.10 $ 45.416  Millions$ 3.753  Millions
Organovo Holdings, Inc.  12.01 $ 38.574  Millions$ 3.212  Millions
Evelo Biosciences, Inc.  11.88 $ 133.282  Millions$ 11.216  Millions


             
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

GRAF's Profile

Stock Price

GRAF's Financials

Business Description

Fundamentals

Charts & Quotes

GRAF's News

Suppliers

GRAF's Competitors

Customers & Markets

Economic Indicators

GRAF's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2019 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071